Close
Smartlab Europe
Inizio Ignite

Veeva Vault LIMS to Support Civica Rx Quality Control

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Therapeutic Frontiers in Malignant Mesothelioma Management

Malignant mesothelioma is one of oncology’s most challenging diagnoses....

CRO Clinical Trials: Structure and Purpose in Modern Research

Clinical trials require carefully organized processes to ensure that...

AstraZeneca-Modella AI Acquisition to Speed Oncology R&D

AstraZeneca has agreed to acquire Boston-based Modella AI as...
- Advertisement -

Veeva Systems  announced that Civica Rx has adopted Veeva Vault LIMS to optimize quality control. Vault LIMS builds on Civica’s success with Veeva Vault QMS, Veeva Vault QualityDocs, and Veeva Vault Training and establishes a foundation for unified lab and quality processes to support a new manufacturing facility.

“We guarantee generic drug volumes for our partner hospitals and health systems, so having a cloud LIMS solution is a top priority,” said Jay Benson, chief manufacturing and supply chain officer at Civica. “Veeva Vault LIMS will simplify our internal manufacturing and testing while driving right first time, lead time adherence, and visibility across the value chain.”

Civica will improve productivity and speed with a unified quality ecosystem. Within Vault LIMS, lab professionals will be able to reference relevant methods and specifications stored in Vault QualityDocs and surface relevant quality events from Vault QMS during final QC review. The unification ensures up-to-date information and improves transparency.

“Veeva Vault LIMS will help Civica create an advanced quality control lab with a simple and efficient user experience,” said Jason Boyd, senior director, Veeva Vault LIMS. “We’re excited to partner with Civica to help them gain agility in delivering affordable generic medicines to patients.”

Latest stories

Related stories

Therapeutic Frontiers in Malignant Mesothelioma Management

Malignant mesothelioma is one of oncology’s most challenging diagnoses....

CRO Clinical Trials: Structure and Purpose in Modern Research

Clinical trials require carefully organized processes to ensure that...

AstraZeneca-Modella AI Acquisition to Speed Oncology R&D

AstraZeneca has agreed to acquire Boston-based Modella AI as...

Novartis, SciNeuro Brain Shuttle Deal Expands Neuroscience

Novartis has entered into a licensing agreement with SciNeuro...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »